135 related articles for article (PubMed ID: 28035468)
21. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
22. Extracellular Matrix-Associated Pathways Promote the Progression of Gastric Cancer by Impacting the Dendritic Cell Axis.
Wang Z; Wang Z; Hu X; Han Q; Chen K; Pang G
Int J Gen Med; 2021; 14():6725-6739. PubMed ID: 34675633
[TBL] [Abstract][Full Text] [Related]
23. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W
Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256
[TBL] [Abstract][Full Text] [Related]
24. Protein expression profiling and molecular classification of gastric cancer by the tissue array method.
Lee HS; Cho SB; Lee HE; Kim MA; Kim JH; Park DJ; Kim JH; Yang HK; Lee BL; Kim WH
Clin Cancer Res; 2007 Jul; 13(14):4154-63. PubMed ID: 17634543
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
26. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
27. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
[TBL] [Abstract][Full Text] [Related]
28. In silico analysis of stomach lineage specific gene set expression pattern in gastric cancer.
Pandi NS; Suganya S; Rajendran S
Biochem Biophys Res Commun; 2013 Oct; 439(4):539-46. PubMed ID: 24025679
[TBL] [Abstract][Full Text] [Related]
29. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of survival-associated alternative splicing events in gastric cancer.
Zhang S; Hu Z; Lan Y; Long J; Wang Y; Chen X; Xu X; Zeng Z; Ouyang Y
Aging (Albany NY); 2020 Nov; 12(21):21923-21941. PubMed ID: 33186122
[TBL] [Abstract][Full Text] [Related]
31. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
[TBL] [Abstract][Full Text] [Related]
32. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
Park SK; Park YS; Ahn JY; Do EJ; Kim D; Kim JE; Jung K; Byeon JS; Ye BD; Yang DH; Park SH; Hwang SW; Jung HY; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
[TBL] [Abstract][Full Text] [Related]
33. A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response.
Busuttil RA; George J; Tothill RW; Ioculano K; Kowalczyk A; Mitchell C; Lade S; Tan P; Haviv I; Boussioutas A
Clin Cancer Res; 2014 May; 20(10):2761-72. PubMed ID: 24658156
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profile towards the prediction of patient survival of gastric cancer.
Xu ZY; Chen JS; Shu YQ
Biomed Pharmacother; 2010 Feb; 64(2):133-9. PubMed ID: 20005068
[TBL] [Abstract][Full Text] [Related]
35. Comparative transcriptome analysis between metastatic and non-metastatic gastric cancer reveals potential biomarkers.
Feng D; Ye X; Zhu Z; Wei Z; Cai Q; Wang Y
Mol Med Rep; 2015 Jan; 11(1):386-92. PubMed ID: 25334039
[TBL] [Abstract][Full Text] [Related]
36. Identification of recurrence-related genes by integrating microRNA and gene expression profiling of gastric cancer.
Yan Z; Xiong Y; Xu W; Li M; Cheng Y; Chen F; Ding S; Xu H; Zheng G
Int J Oncol; 2012 Dec; 41(6):2166-74. PubMed ID: 23007704
[TBL] [Abstract][Full Text] [Related]
37. Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.
Yen CC; Yeh CN; Cheng CT; Jung SM; Huang SC; Chang TW; Jan YY; Tzeng CH; Chao TC; Chen YY; Yang CY; Ho CL; Fletcher JA
Ann Surg Oncol; 2012 Oct; 19(11):3491-9. PubMed ID: 22588468
[TBL] [Abstract][Full Text] [Related]
38. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
39. Combinations of gene ontology and pathway characterize and predict prognosis genes for recurrence of gastric cancer after surgery.
Fan H; Guo Z; Wang C
DNA Cell Biol; 2015 Sep; 34(9):579-87. PubMed ID: 26154702
[TBL] [Abstract][Full Text] [Related]
40. Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis.
Wu Z; Tan J; Zhuang Y; Zhong M; Xiong Y; Ma J; Yang Y; Gao Z; Zhao J; Ye Z; Zhou H; Zhu Y; Lu H; Hong X
Cancer Cell Int; 2021 Dec; 21(1):668. PubMed ID: 34906153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
